PF-04634817
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for PF-04634817, covering 2010-10-13 to 2024-03-01. Get the full timeline:
Most recent: Clinical Trial Update: PF-04634817 Renal Impairment Study [Phase 1]